The use of individual risks rather than PopulationAverages in cost-effectiveness modeling

Slični predmeti

• The use of individual risks rather than population averages in cost-effectiveness modeling
  od: Van Staa, T, i dr.
  Izdano: (2006)
• Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
  od: van Staa, T, i dr.
  Izdano: (2007)
• The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
  od: van Staa, T, i dr.
  Izdano: (2007)
• Not all patients are average: The importance of recognising patient heterogeneity
  od: Van Staa, T, i dr.
  Izdano: (2006)
• Not all patients are average: The importance of epidemiological data in pharmacoeconomic modeling
  od: van Staa, T, i dr.
  Izdano: (2006)